Improvement in quality of life for cancer patients treated with epoetin alfa

European Journal of Cancer Care

Volumn 10, Issue 3, 2001, Pages 183-191

  Libretto, S E ^a   Barrett Lee, P J ^b   Branson, K ^c   Gorst, D W ^d   Kaczmarski, R ^e   McAdam, K ^f   Stevenson, P ^g   Thomas, R ^h  

^a Janssen Cilag Ltd   (United Kingdom)

^b VELINDRE CANCER CENTRE   (United Kingdom)

^c CHRISTIE HOSPITAL   (United Kingdom)

^d ROYAL LANCASTER INFIRMARY   (United Kingdom)

^e HILLINGDON HOSPITAL   (United Kingdom)

^f PETERBOROUGH DISTRICT HOSPITAL   (United Kingdom)

^g NEWCASTLE GENERAL HOSPITAL   (United Kingdom)

^h BEDFORD HOSPITAL   (United Kingdom)

Author keywords

Epoetin alfa; Human erythropoietin; Quality of life

Indexed keywords

ANTIANEMIC AGENT; RECOMBINANT ERYTHROPOIETIN;

AGED; ANEMIA; ARTICLE; BLOOD; CASE REPORT; FATALITY; FEMALE; HUMAN; MALE; MIDDLE AGED; NEOPLASM; QUALITY OF LIFE;

AGED; ANEMIA; EPOETIN ALFA; FATAL OUTCOME; FEMALE; HEMATINICS; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; QUALITY OF LIFE;

EID: 0035467851     PISSN: 09615423     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2354.2001.00264.x     Document Type: Article

References (31)

1. Abels R. (1993) Erythropoietin for anaemia in cancer patients. European Journal of Cancer 29A (Suppl. 2), S2-S8.
2. Barrett-Lee P.J., Bailey N.P., O'Brien M.E.R. et al. (2000) Large scale UK audit of blood transfusion requirements and anaemia in patients receiving cytotoxic chemotherapy. British Journal of Cancer 82, 93-97.
3. Bray G.L. & Reaman G.H. (1991) Erythropoietin deficiency: a complication of cisplatin therapy and its treatment with recombinant human erythropoietin. American Journal of Pediatric Hematology/Oncology 13, 426-430.
4. Cascinu S., Fedeli A., Fedili S.L. et al. (1993) Cisplatin-associated anaemia treated with subcutaneous erythropoietin. A pilot study. British Journal of Cancer 67, 156-158.
5. Cascinu S., Fedeli A., Del Ferro E. et al. (1994) Recombinant human erythropoietin treatment in cisplatin-associated anaemia: a randomized, double-blind trial with placebo. Journal of Clinical Oncology 12, 1058-1062.
6. Case D.C. Jr, Bukowski R.M., Carey R.W. et al. (1993) Recombinant human erythropoietin therapy for anemic cancer patients on combination chemotherapy. Journal of the National Cancer Institute 85, 801-806.
7. Cella D. (1998) Factors influencing quality of life in cancer patients: anaemia and fatigue. Seminars in Oncology 25 (Suppl. 7), 43-46.
8. Cella D.F. & Bonomi A.E. (1995) Measuring quality of life: 1995 update. Oncology 9 (Suppl. 11), 47-60.
9. Cleeland C.S., Demetri G.D., Glaspy J. et al. (1999) Identifying haemoglobin level for optimal quality of life: results of an incremental analysis. Proceedings of the American Society of Clinical Oncology, 35th Annual Meeting, May 15-18, 18 (Abstract), 574a.
10. Coates A., Gebski V., Bishop J.F. et al. (1987) Improving the quality of life during chemotherapy for advanced breast cancer. A comparison of intermittent and continuous treatment strategies. New England Journal of Medicine 317, 1490-1495.
11. Curt G.A., Breithbart W. & Cella D. (1999) Impact of cancer-related fatigue on the lives of patients. Proceedings of the American Society of Clinical Oncology 18, 573.
12. Dainiak N., Kalkani V., Howard D. et al. (1983) Mechanisms of abnormal erythropoiesis in malignancy. Cancer 51, 1101-1106.
13. Dalton W.S. (1998) Anaemia in multiple myeloma and its management. Cancer Control 5 (Suppl.), 46-50.
14. Demetri G.D., Kris M., Wade J. et al. (1998) Quality-of-Life benefit in chemotherapy patients treated with epoetin alfa is independent of disease response or tumor type: results from a prospective community oncology study. Journal of Clinical Oncology 16, 3412-4325.
15. Glaspy J., Bukowski R., Steingerg D. et al. (1997) Impact of therapy with epoetin alfa on clinical outcomes in patients with non-myeloid malignancies during cancer chemotherapy in community oncology practice. Journal of Clinical Oncology 15, 1218-1234.
16. Henry D.H. & Abels R.I. (1994) Recombinant human erythropoietin in the treatment of cancer and chemotherapy-induced anemia: Results of double-blind and open-label follow-up studies. Seminars in Oncology 21, 21-28.
17. Henry D.H., Brooks B.J., Case D.C. et al (1995) Recombinant human erythropoietin therapy for anemic cancer patients receiving cisplatin chemotherapy. Cancer Journal from Scientific American 1, 252-260.
18. Irvine D.M., Vincent L., Bubela N. et al. (1991) A critical appraisal of the research literature investigating fatigue in the individual with cancer. Cancer Nursing 14, 188-199.
19. Irvine D., Vincent L., Graydon J.E. et al. (1994) The prevalence and correlates of fatigue in patients receiving treatment with chemotherapy and radiotherapy. Cancer Nursing 17, 367-378.
20. Leigeb C., Pecherstorfer M., Fritz E. et al. (1994) Quality of life in chronic anemia of cancer during treatment with recombinant human erythropoietin. Cancer 73, 2535-2542.
21. Littlewood T.J., Bajetta E., Cella D. et al. (1999) Efficacy and quality of life outcomes of epoetin alfa in a double-blind, placebo-controlled multicenter study of cancer patients receiving non-platinum containing chemotherapy. Proceedings of the American Society of Clinical Oncology, 35th Annual Meeting, May 15-18, 18 (Abstract), 2217.
22. Ludwig H. & Fritz E. (1998) Anaemia in cancer patients. Seminars in Oncology 25 (Suppl. 7), 2-6.
23. Ludwig H., Sundal E., Pecherstorfer M. et al. (1995) Recombinant human erythropoietin for the correction of cancer associated anemia with and without concomitant cytotoxic chemotherapy. Cancer 76, 2319-2329.
24. Miller C.B., Jones R.J., Piantadosi S. et al. (1990) Decreased erythropoietin response in patients with the anemia of cancer. New England Journal of Medicine 322, 1689-1692.
25. Miller C.B., Platanias L.C., Mills S.R. et al. (1992) Phase I-II trial of erythropoietin in the treatment of cisplatin-associated anemia. Journal of the National Cancer Institute 84, 98-103.
26. Pedrazzoli P., Ponchio L., Poggi G. et al. (1993) Response to recombinant human erythropoietin (rHuEpo) in patients with cancer-related anaemia. European Journal of Cancer 29 (Suppl. 6), S53, (Abstract) 260.
27. Platanias L.C., Miller C.B., Mick R. et al. (1991) Treatment of chemotherapy-induced anemia with recombinant human erythropoietin in cancer patients. Journal of Clinical Oncology 9, 2021-2026.
28. Rose E., Rai K., Revicki D. et al. (1994) Clinical and health status assessments in anemic chronic lymphocytic leukemia (CCL) patients treated with epoetin alfa (EPO). Blood 84 (Suppl. 1), 526a, (Abstract) 2091.
29. Skillings J.R., Sridhar F.G., Wong C. et al. (1993) The frequency of red cell transfusion for anaemia in patients receiving chemotherapy. American Journal of Clinical Oncology 16, 22-25.
30. Spivak J.L. (1994) Cancer-related anaemia: its causes and characteristics. Seminars in Oncology 21 (Suppl. 3), 3-8.
31. Stone P., Richardson A., Ream E. et al. (2000) Cancer-related fatigue: inevitable, unimportant and untreatable? Results of a multi-centre patient survey. Annals of Oncology 11, 971-975.